The MRC has announced nine short-listed proposals that could be funded under the second phase of its £60m Stratified Medicine Initiative, which aims to boost our understanding of why groups of patients with the same diagnosis differ in their response to treatment.
Parties who believe that they could make a valuable contribution to these short-listed proposals are invited to contact the relevant teams.
The nine short-listed applications for full proposals are in asthma, cancer, hypertension, the lung condition idiopathic pulmonary fibrosis, lupus, a kidney disease called nephrotic syndrome and transplantation.
